The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms

Cancer Cytopathology

Volumn 118, Issue 3, 2010, Pages 137-145

  Roh, Michael H ^a   Dal Cin, Paola ^b   Silverman, Stuart G ^b   Cibas, Edmund S ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cytogenetics; Cytology; Fine needle aspiration; Fluorescence in situ hybridization; Kidney; Percutaneous biopsy; Renal cell carcinoma

Indexed keywords

ORGANOPHOSPHATE; PHOSPHORIC ACID TRIS(2,3 DIBROMOPROPYL) ESTER; TRIS(2,3-DIBROMOPROPYL)PHOSPHATE;

ARTICLE; CHROMOSOME ABERRATION; CYTOGENETICS; FEASIBILITY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KIDNEY TUMOR; NEEDLE BIOPSY; PATHOLOGY;

BIOPSY, FINE-NEEDLE; CHROMOSOME ABERRATIONS; CYTOGENETICS; FEASIBILITY STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; PHOSPHORIC ACID ESTERS;

EID: 77954667449     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20077     Document Type: Article

References (36)

1. Kelley CM, Cohen MB, Raab SS. Utility of fine-needle aspiration biopsy in solid renal masses. Diagn Cytopathol. 1996;14:14-19.
2. Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses in the adult patient: The role of percutaneous biopsy. Radiology. 2006;240:6-22.
3. Tuncali K, vanSonnenberg E, Shankar S, Mortele KJ, Cibas ES, Silverman SG. Evaluation of patients referred for percutaneous ablation of renal tumors: Importance of a preprocedural diagnosis. AJR Am J Roentgenol. 2004;183:575-582.
4. Renshaw AA, Cibas ES. Chapter 14: Kidney and Adrenal Gland. In: Cibas ES, Ducatman BS, eds. Cytology: Diagnostic Principles and Clinical Correlates. Philadelphia, Pa: Saunders/Elsevier, 2009:403-431.
5. Renshaw AA, Lee KR, Madge R, Granter SR. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma. Acta Cytologica. 1997;41:987-994.
6. Dal Cin P, Ligon A. Tumors of the Urinary Tract. In: Heim S, Mitelman F, eds. Cancer Cytogenetics. New York: John Wiley & Sons, Inc.; 2009:465-493.
7. Fletcher JA, Kozakewich HP, Hoffer FA, et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med. 1991;324:436-442.
8. Dal Cin P. Genetics in renal cell carcinoma. Curr Opin Urol. 2003;13:463-466.
9. Renshaw AA, Fletcher JA. Trisomy 3 in renal cell carcinoma. Mod Pathol. 1997;10:481-484.
10. Beck SDW, Patel MI, Snyder ME, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann of Surg Oncol. 2004;11:71-77.
11. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612-624.
12. Cindolo L, De la Taille A, Schips L, et al. Chromophobe renal cell carcinoma: Comprehensive analysis of 104 cases from multicenter European database. Urology. 2005;65:681-686.
13. Delahunt B, Bethwaite PB, Nacey JN. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology. 2007;39:459-465.
14. Peyromaure M, Misrai V, Thiounn N, et al. Chromophobe renal cell carcinoma-analysis of 61 cases. Cancer. 2004; 100:1406-1410.
15. Skinnider BE, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue - Potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol. 2005;29:747-754.
16. Zhou M, Roma A, Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med. 2005;25:247-257.
17. Gobbo S, Eble JN, MacLennan GT, et al. Renal cell carcinomas with papillary architecture and clear cell components. The utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Path. 2008;32:1780-1786.
18. Foster K, Prowse A, Vandenberg A, et al. Somatic mutations of the Von Hippel-Lindau disease tumor suppressor gene in nonfamilial clear cell renal carcinoma. Hum Mol Genet. 1994;3:2169-2173.
19. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet. 1994; 7:85-90.
20. Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the Von Hippel- Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 1994;54:2852-2855.
21. Whaley JM, Naglich J, Gelbert L, et al. Germ-line mutations in the Von Hippel-Lindau tumor-suppressor gene are similar to somatic Von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet. 1994;55:1092-1102.
22. Balzarini P, Dal Cin P, Roskams T, et al. Histology may depend on the presence of partial monosomy or partial trisomy 3 in renal cell carcinoma. Cancer Genet Cytogenet. 1998;105:6-10.
23. Corless CL, Aburatani H, Fletcher JA, Housman DE, Amin MB, Weinberg DS. Papillary renal cell carcinoma - Quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn Mol Pathol. 1996;5:53-64.
24. Kovacs G. Molecular differential pathology of renal-cell tumors. Histopathology. 1993;22:1-8.
25. Kovacs G, Frisch S. Clonal chromosome-abnormalities in tumor-cells from patients with sporadic renal cell carcinomas. Cancer Res. 1989;49:651-659.
26. Kovacs A, Kovacs G. Low chromosome-number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer. 1992;4:267-268.
27. Speicher MR, Schoell B, Dumanoir S, et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. American J Pathol. 1994;145:356-364.
28. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World Health Organization classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARCC Press; 2004.
29. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma-a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192.
30. Sidhar SK, Clark J, Gill S, et al. The t(X;l)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet. 1996;5:1333-1338.
31. Drut R, Drut RM. Renal and extrarenal congenital rhabdoid tumor: diagnosis by fine-needle aspiration biopsy and FISH. Diagn Cytopathol. 2002;27:32-34.
32. Beroukhim R, Brunet JP, Di Napoli A, et al. Patterns of gene expression and copy-number alterations in Von-Hippel Lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 2009;69:4674-4681.
33. Pack SD, Zbar B, Pak E, et al. Constitutional von Hippel- Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res. 1999;59: 5560-5564.
34. Yamaguchi S, Yoshihiro S, Matsuyama H, et al. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear cell renal cell carcinoma. Clin Genet. 2003;63:184-191.
35. Barocas DA, Mathew S, DelPizzo JJ, et al. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU International. 2006;99:290-295.
36. Lefevre M, Couturier J, Sibony M, et al. Adult papillary renal tumor with oncocytic cells - Clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol. 2005;29:1576-1581.